Advanced search×

Absence of merkel cell polyoma virus in cutaneous melanoma.

Ivette Koburger, Diana Meckbach, Gisela Metzler, Uwe Fauser, Claus Garbe, and Jürgen Bauer

Exp Dermatol 20(1):78-9 (2011) PMID 21054561

Recently, merkel cell polyoma virus (MCPyV) has been described in 80% of merkel cell carcinomas (MCC). Similar to MCC, melanoma incidence is increased in immuno-suppressed patients. We hypothesized that MCPyV may play a role in melanoma development as well. We selected 95 archival, paraffin-embedded primary melanomas. DNA was obtained from micro-dissected tissue and amplified with PCR primer sets specific for the MCPyV T-antigen locus (LT1 and LT3) and for the VP1 gene. None of the 95 melanoma samples did show LT1, LT3, or VP1 fragment amplification. In conclusion, there is no evidence that MCPyV infection plays a role in cutaneous melanoma development.

DOI: 10.1111/j.1600-0625.2010.01175.x
Version: za2963e q8za6 q8zbf q8zcd q8zdf q8ze1 q8zf2 q8zgc

Similar articles you may find interesting…

  1. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
    Laura L Held, Thomas K TK Eigentler, ... Jürgen J Bauer

    J Dtsch Dermatol Ges 9(7):510-6 (2011) PMID 21244632

    Our understanding of oncogenetics and of the molecular mechanisms involved in melanoma development and signaling has dramatically changed in recent years. Today, melanomas are also classified based on molecular alterations. Emerging molecular therapies are targeted against specific mutations in mela...
  2. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of m...
    Thomas K Eigentler, Adina Figl, ... Dirk Schadendorf

    Cancer 117(8):1697-703 (2011) PMID 21061349

    This multicenter study aimed to identify prognostic factors in patients with brain metastases from malignant melanoma (BM-MM).
  3. Systematic review of medical treatment in melanoma: current status and future prospects.
    Claus C Garbe, Thomas K TK Eigentler, ... John M JM Kirkwood

    Oncologist 16(1):5-24 (2011) PMID 21212434

    The incidence of melanoma is increasing worldwide, and the prognosis for patients with high-risk or advanced metastatic melanoma remains poor despite advances in the field. Standard treatment for patients with thick (≥2.0 mm) primary melanoma with or without regional metastases to lymph nodes is s...
    View PDF